Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

13 Feb 2015 08:18

RNS Number : 8037E
Fiske PLC
13 February 2015
 



 

 

13 February 2015

 

 

Fiske Plc

('Fiske' or 'the Company')

 

Interim Results

 

Fiske Plc (the 'Company') announces its interim results for the six months ended 30 November 2014. In accordance with rule 26 of the AIM Rules for Companies this information is also available, under the Investors section, at the Company's website, http://www.fiskeplc.com .

 

For further information please contact:

 

• Salmaan Khawaja/Richard Tonthat, Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

 

• Gerard Luchini, Fiske Plc - Compliance Officer

(tel: 020 7448 4700)

 

 

Chairman's Statement

 

 

 

 

 

We have experienced a disappointing half year with a pre tax loss of £165,000. This is partly the result of relatively dull and inactive markets, as has been demonstrated by our competitors, but we have in the past been both nimble and lean enough to counteract outside influences and this we have failed to do.

 

Our institutional business, which we value highly but remains a relatively small part of our revenue, suffered from two factors. Firstly an institutional team, which joined us two and a half years ago left at the beginning of the half year. Secondly, the commission rate on institutional business has been reducing and has roughly halved over the past twelve months under the twin influences of regulation and competition. The outlook in this area is not encouraging, but we expect our small team to continue to make a contribution.

 

We have invested considerable management time in the process of a major systems upgrade. Whilst this is a noticeable distraction from day to day stockbroking, it is an essential step to enable us to expand our key business of wealth management and private client stockbroking. This process will continue for most of the current calendar year, but we expect our upgraded front office systems to provide a much improved service to our clients, to bring in house some of our outsourced activities and enable us to attract new private client stockbrokers to the firm. Wealth management is our core business and we intend to ensure that we can expand this profitably in the future.

 

Looking at the wider investment scene, both national and international, it appears that the performance of economies and in particular of corporate entities has become of less importance in determining market movements as the relative importance of the behaviour of Central Banks increases. This is an economic anomaly on a par with the belief in the late 1990's that markets would never fall due to the "Greenspan put". That fallacy exploded in 2001. Ultimately earnings and dividends determine share prices, but Quantitative Easing, the euphemism for printing money, can distort matters for some time as we have recently experienced. Last October as the US was ending Quantitative Easing, the markets were apprehensive. The Japanese then launched a massive new stimulus. Now the European Central Bank believes it is its turn. The truth is that all panacea lose their power when they become repetitive and the anticipation and announcement have more impact than the protracted execution. The fact that the Swiss National Bank was forced to abandon its cap was clear proof that the bond market is ultimately more powerful than Central Banks. Current market levels are not justified on historical parallels, either earnings need to increase substantially, a questionable outcome, or we are vulnerable to a major setback.

 

We retain a solid balance sheet. We note that our major investment in the shares of Euroclear continues to prosper and we have considerable confidence in both its short and medium term performance. We view our own future with confidence and accordingly we will maintain our current modest dividend level of 0.25p per share which will be paid out of reserves.

 

 

 

 

C F Harrison Chairman

12 February 2015

 

 

 

Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2014

 

 

 

Six months ended

30 November 2014

Unaudited

Six months ended

30 November 2013

Unaudited

Year ended

31 May 2014

Audited

£'000

£'000

£'000

Fee and commission income

1,559

2,061

4,178

Fee and commission expenses

(301)

(532)

(1,139)

Net fee and commission income

1,258

1,529

3,039

Other income

60

102

132

Total revenue

1,318

1,631

3,171

Profit on investments held for trading

3

3

3

Operating expenses

(1,497)

(1,472)

(3,061)

Operating (loss)/profit

(176)

162

113

Investment revenue

7

66

134

Finance income

10

12

22

Finance costs

(3)

(1)

(1)

(Loss)/profit on ordinary activities before taxation

(162)

239

268

Taxation

27

(37)

(37)

(Loss)/profit on ordinary activities after taxation

(135)

202

231

Other comprehensive income/(expense)

Movement in unrealised appreciation of investments

68

115

69

Deferred tax on movement in unrealised appreciation of investments

 

(11)

 

(23)

 

(10)

Net other comprehensive (expense)/ income

57

92

59

Total comprehensive (loss)/income for the period/year attributable to equity shareholders

 

(78)

 

294

 

290

Earnings per ordinary share (pence), excluding other comprehensive income

Basic

(1.6)p

2.4p

2.7p

Diluted

(1.6)p

2.4p

2.7p

 

All results are from continuing operations and are attributable to equity shareholders of the parent company.

Consolidated Statement of Changes in Equity

 

 

 

 

Share Capital

Share Premium

Revaluation Reserve

Retained Earnings

Total Equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 December 2013

2,115

1,222

1,294

540

5,171

Profit on ordinary activities after taxation

-

-

-

29

29

Other comprehensive income

-

-

(33)

-

(33)

Total comprehensive income for period

-

-

(33)

29

(4)

Dividends paid

-

-

-

(30)

(30)

Balance at 31 May 2014

2,115

1,222

1,261

539

5,137

Loss on ordinary activities after taxation

-

-

-

(135)

(135)

Other comprehensive income

-

-

57

-

57

Total comprehensive income for period

-

-

57

(135)

(78)

Dividends paid

-

-

-

(31)

(31)

Balance at 30 November 2014

2,115

1,222

1,318

373

5,028

 

Consolidated Statement of Financial Position

30 November 2014

 

 

 

As at

30 November 2014

Unaudited

As at

30 November 2013

Unaudited

As at

31 May 2014

Audited

£'000

£'000

£'000

Non-current assets

Goodwill

395

395

395

Property, plant and equipment

38

41

35

Available-for-sale investments

2,438

2,411

2,365

Total non-current assets

2,871

2,847

2,795

Current assets

Trade and other receivables

2,923

12,080

5,810

Investments held for trading

90

282

124

Cash and cash equivalents

3,485

3,395

3,957

Total current assets

6,498

15,757

9,891

Current liabilities

Trade and other payables

4,020

13,033

7,211

Current tax liabilities

11

90

38

Total current liabilities

4,031

13,123

7,249

Net current assets

2,467

2,634

2,642

Non-current liabilities

Deferred tax liabilities

310

310

300

Total non-current liabilities

310

310

300

Net assets

5,028

5,171

5,137

Equity

Share capital

2,115

2,115

2,115

Share premium

1,222

1,222

1,222

Revaluation reserve

1,318

1,294

1,261

Retained earnings

373

540

539

Shareholders' equity

5,028

5,171

5,137

 

Consolidated Cash Flow Statement

For the six months ended 30 November 2014

 

 

 

Six months ended

30 November 2014

Unaudited

Six months ended

30 November 2013

Unaudited

Year ended

31 May 2014

Audited

£'000

£'000

£'000

Operating (loss)/profit

(176)

162

113

Depreciation of property plant and equipment

12

13

27

Decrease/(increase) in investments held for trading

34

(247)

(89)

Decrease/(increase) in receivables

2,887

434

6,704

(Decrease)/increase in payables

(3,190)

263

(5,560)

Cash (used in)/ generated from operations

(433)

625

1,195

Tax paid

-

(1)

(50)

Net cash (used in)/generated from operating activities

(433)

624

1,145

Investing activities

Interest received

10

12

22

Investment income received

7

66

134

Interest paid

(5)

(1)

-

Purchases of available-for-sale investments

(5)

-

-

Purchases of property, plant and equipment

(16)

(16)

(24)

Net cash (used in)/ generated from investing activities

(9)

61

132

Financing activities

Dividends paid

(30)

(21)

(51)

Net cash used in financing activities

(30)

(21)

(51)

Net (decrease)/ increase in cash and cash equivalents

(472)

664

1,226

Cash and cash equivalents at beginning of period

3,957

2,731

2,731

Cash and cash equivalents at end of period/year

3,485

3,395

3,957

 

 

Notes to the Interim Financial Statements

1. Basis of preparation

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.

The figures and financial information for the period ended 31 May 2014 are extracted from the latest published audited financial statements of the Group and do not constitute the statutory financial statements for that period. The audited financial statements for the period ended 31 May 2014 have been filed with the Registrar of Companies. The report of the independent auditors on those financial statements contained no qualification or statement under section 498(2) or section 498(3) of the Companies Act 2006.

The condensed set of financial statements has been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted by the European Union. The financial information has been prepared under the historical cost convention, except for the revaluation of certain financial instruments. The same accounting policies, presentation and methods of computation are followed in these condensed set of financial statements as applied in the Group's latest, and intends to use in preparing its next, annual audited financial statements. While the financial figures included in this half-yearly report have been computed in accordance with IFRSs applicable to interim periods, this half-yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

The directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing this half-yearly financial report.

2. Taxation

The tax charge for the six months to 30 November 2014 reflects all the necessary provisions for current tax, taking into account the availability of losses brought forward, and movements in deferred tax. In arriving at the effective tax rate account has been taken of the change in the rate of tax charged and the disallowance of the cost of share-based payments charged to the consolidated statement of comprehensive income.

3. Dividends paid

Dividends paid of £30,000 (2013 - £21,000) refer to the second interim dividend paid for the preceding year.

The Interim dividend of 0.25p will be paid on 20 March 2015 to shareholders on the register on 27 February 2015. The shares will be marked ex-dividend on 26 February 2015.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFLDFSIFLIE
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.